NCT02462499View on ClinicalTrials.gov

Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Chronic Central Serous Chorioretinopathy
Interventions
DRUG

Inspra (eplerenone)

Trial Locations (1)

1085

Semmelweis University, Department of Ophthalmology, Budapest

All Listed Sponsors
lead

Semmelweis University

OTHER

NCT02462499 - Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population | Biotech Hunter | Biotech Hunter